Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26977344 | 0.87 | ALOX15 (0.57) | ALOX15ALDH1A1TSHRPTPN1LMNA | |
| SCHEMBL31549495 | 0.85 | ALOX15 (0.41) | ALOX15ALDH1A1TSHRPTPN1LMNA | |
| SCHEMBL26977542 | 0.84 | ALOX15 (0.54) | ALOX15ALDH1A1TSHRPTPN1PTPN2 | |
| SCHEMBL26977276 | 0.84 | ALOX15 (0.56) | ALOX15ALDH1A1TSHRPTPN1LMNA | |
| SCHEMBL26977271 | 0.83 | ALOX15 (0.53) | ALOX15ALDH1A1PTPN1PTPN2DUSP3 | |
| SCHEMBL26977518 | 0.81 | ALOX15 (0.53) | ALOX15ALDH1A1TSHRPTPN1LMNA | |
| SCHEMBL26977571 | 0.77 | ALOX15 (0.49) | ALOX15ALDH1A1TSHRPTPN1LMNA | |
| SCHEMBL7552905 | 0.77 | ALOX15 (0.70) | ALOX15ALDH1A1TSHRPTPN1LMNA | |
| SCHEMBL26977297 | 0.76 | ALOX15 (0.51) | ALOX15ALDH1A1TSHRPTPN1LMNA | |
| SCHEMBL7948545 | 0.76 | ALOX15 (0.55) | ALOX15ALDH1A1TSHRLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12516012-B2 | Odorous compounds and method of preparation thereof | S.H. Kelkar and Company Limited (IN) | 2026-01-06 | — | — | US | disclosed |
| CN-115803309-B | Odorous compounds and process for their preparation | 丝趣科尔卡有限公司 | 2024-10-11 | — | — | CN | disclosed |
| US-20240262776-A1 | Odorous Compounds and Method of Preparation Thereof | S.H. Kelkar and Company Limited (IN) | 2024-08-08 | — | — | US | disclosed |
| EP-4298078-A1 | ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF | S. H. Kelkar and Company Limited (IN) | 2024-01-03 | — | — | EP | disclosed |
| CN-115803309-A | Odorous compounds and methods of making the same | 丝趣科尔卡有限公司 | 2023-03-14 | — | — | CN | disclosed |
| WO-2022180642-A1 | ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF | S. H. KELKAR AND COMPANY LIMITED (IN) | 2022-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240262776-A1 | Odorous Compounds and Method of Preparation Thereof | OR10J3, OR51E2, DECR1 | ALOX15 176/4885ALDH1A1 285/4885TSHR 3830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.